Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114759) titled 'A prospective, randomized, parallel controlled clinical trial of megestrol acetate oral suspension in patients with locally advanced nasopharyngeal carcinoma' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fujian Cancer Hospital
Condition:
Locally Advanced Nasopharyngeal Carcinoma
Intervention:
Experimental group:Megestrol acetate oral suspension + radiotherapy + Nimotuzumab
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental group:34;Control group :34;
Countries of Recruitment:
China
To kn...